YS Biopharma Co., Ltd. (YS)
Total Valuation
YS has a market cap or net worth of $140.52 million. The enterprise value is $173.50 million.
| Market Cap | 140.52M |
| Enterprise Value | 173.50M |
Important Dates
The last earnings date was Friday, May 12, 2023.
| Earnings Date | May 12, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
YS has 93.06 million shares outstanding. The number of shares has decreased by -0.07% in one year.
| Shares Outstanding | 93.06M |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | +859.77% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.11 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.52
| Current Ratio | 1.52 |
| Quick Ratio | 1.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -37.30% |
| Return on Capital (ROIC) | -14.30% |
| Revenue Per Employee | $146,705 |
| Profits Per Employee | -$51,405 |
| Employee Count | 865 |
| Asset Turnover | 1.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, YS has paid $773,749 in taxes.
| Income Tax | 773,749 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | NaN |
| Average Volume (30 Days) | 812,061 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, YS had revenue of $126.90 million and -$44.47 million in losses. Loss per share was -$0.01.
| Revenue | 126.90M |
| Gross Profit | 97.26M |
| Operating Income | -19.20M |
| Pretax Income | -15.18M |
| Net Income | -44.47M |
| EBITDA | -5.02M |
| EBIT | -12.70M |
| Loss Per Share | -$0.01 |
Balance Sheet
The company has $31.92 million in cash and $64.90 million in debt, giving a net cash position of -$32.98 million or -$0.35 per share.
| Cash & Cash Equivalents | 31.92M |
| Total Debt | 64.90M |
| Net Cash | -32.98M |
| Net Cash Per Share | -$0.35 |
| Equity / Book Value | -133.68M |
| Book Value Per Share | -1.44 |
| Working Capital | 41.65M |
Cash Flow
| Operating Cash Flow | -39.44M |
| Capital Expenditures | n/a |
| Free Cash Flow | -39.44M |
| FCF Per Share | -$0.16 |
Margins
Gross margin is 76.65%, with operating and profit margins of -15.13% and -35.04%.
| Gross Margin | 76.65% |
| Operating Margin | -15.13% |
| Pretax Margin | -11.96% |
| Profit Margin | -35.04% |
| EBITDA Margin | -3.96% |
| EBIT Margin | -10.01% |
| FCF Margin | -31.08% |
Dividends & Yields
YS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -31.64% |
| FCF Yield | -28.07% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.07% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |